Veterinary Medicines

Halofusol 0.5 mg/ml oral solution for calves

Authorised
  • Halofuginone lactate
Download as PDF

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Halofusol 0.5 mg/ml oral solution for calves
Halofusol 0,6086 mg/ml Roztwór doustny
Sustanza attiva:
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
  • Użu orali

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    0.61
    milligram(s)
    /
    1.00
    millilitre(s)
Forma farmaċewtika:
  • Soluzzjoni orali
Withdrawal period by route of administration:
  • Oral use
    • Cattle (newborn calf)
      • Meat and offal
        13
        day
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QP51BX01
Status legali tal-provvista:
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Poland
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Bażi ġuridika tal-awtorizzazzjoni tal-prodott:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Laboratorios Karizoo S.A.
Awtorità responsabbli:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Numru tal-awtorizzazzjoni:
  • 3036
Stat Membru ta’ referenza:
Numru tal-proċedura:
  • ES/V/0351/001
Stati Membri Kkonċernati:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."